Related Experiment Video
Updated: Mar 14, 2026
08:34
Left Atrial Stenosis Induced Pulmonary Venous Arterialization and Group 2 Pulmonary Hypertension in Rat
Published on: November 18, 2018
7.8K
Kawasaki Disease at 50 Years.
1Division of Immunology, Program in Rheumatology, Boston Children's Hospital, Boston, Massachusetts.
JAMA Pediatrics
|September 27, 2016
Summary
Kawasaki disease, a childhood vasculitis, can be effectively managed in over 95% of cases with personalized treatments. Early identification of high-risk infants improves outcomes, minimizing long-term cardiac damage.
Area of Science:
- Pediatric rheumatology and cardiology
- Vasculitis research
- Childhood inflammatory diseases
Background:
- Kawasaki disease (KD) is the primary vasculitis affecting children, characterized by fever, rash, and inflammation.
- While symptoms resolve spontaneously, KD poses a risk of coronary artery damage, necessitating specialized care.
- Despite being an orphan disease, KD is a leading cause of acquired pediatric heart disease.
Purpose of the Study:
- To outline the current understanding and management of Kawasaki disease.
- To highlight advances in diagnosis and personalized treatment strategies for KD.
- To emphasize the interdisciplinary approach in studying KD's etiology and pathophysiology.
Main Methods:
- Review of clinical presentation and diagnostic criteria for Kawasaki disease.
- Analysis of treatment protocols, including intravenous immunoglobulin and corticosteroids.
- Stratification of patients based on risk factors for tailored therapy.
Main Results:
- Kawasaki disease can be controlled without sequelae in over 95% of cases.
- Early identification and treatment of high-risk infants (e.g., <6 months) improve outcomes.
- Personalized treatment algorithms are effective for incomplete KD and non-responders.
Conclusions:
- Kawasaki disease management has advanced significantly, with personalized medicine improving outcomes.
- Interdisciplinary collaboration is crucial for understanding KD's genetic and pathophysiological features.
- Research in KD offers insights into other inflammatory conditions.
More Related Videos
05:58Digital Polymerase Chain Reaction Assay for the Genetic Variation in a Sporadic Familial Adenomatous Polyposis Patient Using the Chip-in-a-tube Format
Published on: August 20, 2018
11.5K
07:02Identifying Dysregulated Genes Induced by Kaposi's Sarcoma-associated Herpesvirus KSHV
Published on: September 14, 2010
13.1K
Related Concept Videos
01:24Chronic Kidney Disease II: Clinical Manifestations
876
Chronic Kidney Disease (CKD) progressively impairs multiple body systems due to the accumulation of uremic toxins, which disrupt cellular functions across various organs.Neurologic symptomsNeurologic symptoms often arise early in CKD, as uremic toxin buildup drives changes in cognitive and motor functions. Patients frequently experience fatigue, headache, confusion, difficulty concentrating, and, in severe cases, seizures. Peripheral neuropathy commonly manifests as burning sensations in the...
876
01:25Endocarditis II: Clinical Features of Infective Endocarditis
687
Endocarditis can present various clinical features depending on the causative organism and the patient's underlying health conditions. Initially, the clinical features of infective endocarditis develop gradually, presenting with nonspecific symptoms that can be easily mistaken for other illnesses.General SymptomsEarly symptoms of infective endocarditis are fever, chills, weakness, malaise, fatigue, and weight loss. These symptoms reflect the systemic nature of the infection and the body's...
687
01:18Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Excretion
303
In geriatric patients, renal physiology undergoes significant changes, including diminished renal blood flow and a lower glomerular filtration rate (GFR), leading to alterations in medication clearance. Drugs such as aminoglycoside antibiotics, lithium, and digoxin, which rely on glomerular filtration for removal from the body, particularly impact pharmacokinetics. These drugs tend to have slower clearance rates in older adults, necessitating careful dosage considerations.Evaluation of renal...
303
01:23Rheumatic Heart Disease I: Introduction
735
Rheumatic heart disease or RHD is a chronic condition that results from rheumatic fever, causing permanent damage to the heart valves.Etiology and Risk FactorsIt primarily arises from rheumatic fever, an inflammatory disease that can develop after untreated or inadequately treated group A streptococcal (GAS) pharyngitis. Streptococcus spreads through direct contact with oral or respiratory secretions. While the bacteria are the causative agents, factors like malnutrition, overcrowding, poor...
735
01:25Chronic Kidney Disease I: Introduction
952
Chronic Kidney Disease (CKD) arises when the kidneys progressively lose their ability to function, ultimately leading to end-stage renal disease. At this advanced stage, the kidneys can no longer filter waste or maintain essential body functions, requiring renal replacement therapy (RRT) through dialysis or a kidney transplant for survival.Early-stage chronic kidney disease and detection challengesIn CKD's early stages, symptoms often remain absent because healthy nephrons compensate for...
952
01:24Nephrotic Syndrome I : Introduction
821
Nephrotic Syndrome is a chronic kidney disorder defined by clinical findings such as severe proteinuria, hypoalbuminemia, hyperlipidemia, and edema. These symptoms result from damage to the glomeruli, the kidney’s filtering units, increasing their permeability to proteins.Definition and Meaning:Proteinuria, defined as the loss of more than 3.5 grams of protein per day in adults, is a crucial feature of nephrotic syndrome. This condition is often accompanied by edema, the accumulation of...
821